Higher resistin levels are associated with reduced muscle mass and poorer physical performance in older adults, suggesting that resistin contributes not only to hepatic and adipose insulin resistance but also to sarcopenia and inflammation-driven metabolic impairment, based on observational human evidence [39,40]. Here, RETN is linked to sarcopenia.